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2Abstract
Background: Combatting over-weight or obesity can lead to large fluctuations in an 
individual’s body weight, often referred to as weight cycling or “yo-yo” dieting. Current 
evidence regarding the potentially damaging effects of these changes is conflicting. 
Methods: Here, we assess the metabolic effects of weight cycling in a murine model, 
comprising three dietary switches to normal or high fat diets at 6 week intervals; male 
C57BL/6 mice were fed either a control (C) or high fat (F) diet for 6 weeks (n=140/group). C 
and F groups were then either maintained on their initial diet (CC and FF respectively) or 
switched to a high fat (CF) or control (FC) diet (n=35/group). For the final 6 week interval, 
CC and CF groups were returned to the control diet (CCC and CFC groups) while FC and 
FF groups were placed on a high fat diet (FCF and FFF) (n=28/group).
Results: For the majority of metabolic outcomes changes aligned with dietary switches; 
however assessment of neuropeptides and receptors involved in appetite regulation and 
reward signalling pathways reveal variable patterns of expression. Furthermore, we 
demonstrate that multiple cycling events leads to a significant increase in internal fat 
deposition, even when compared to animals maintained on a high fat diet (Internal Fat: FCF: 
7.4 ± 0.2g vs. FFF: 5.6 ± 0.2g; p<0.01).
Conclusions: Increased internal adipose tissue is strongly linked to the development of 
metabolic syndrome associated conditions such as type 2 diabetes, cardiovascular disease 
and hypertension. While further work will be required to elucidate the mechanisms 
underlying the neuronal control of energy homeostasis, these studies provide a causative 
link between weight cycling and adverse health.
3Introduction
Effective treatments for obesity and its related morbidities are hindered by both post-surgical 
complications following bariatric surgery, and side-effects associated with approved anti-
obesity drugs 1. Reduced calorie intake and increased energy expenditure via exercise 
represent the least invasive means of therapy. However, these lifestyle changes are often 
unsuccessful in the long-term 2, which can lead to multiple, unsuccessful attempts to lose 
weight, resulting in weight cycling, or “yoyo dieting”.
Although undesirable, as it represents a failure to maintain weight loss, there are conflicting 
data on whether weight cycling episodes induce a metabolically adverse outcome. Several 
studies indicate no association between weight-cycling and body composition, metabolic 
profile, energy expenditure or cardiovascular risk 3-7. In contrast, additional reports have 
linked weight cycling to future weight gain, altered fat distribution and increased 
cardiovascular and metabolic risk, 8-12.
These inconsistencies are mirrored in animal studies; with several papers reporting 
increased fat mass and internal adiposity, insulin resistance and hypertension in weight 
cycling models 13-15, while others find no association 16, 17. In both human and preclinical 
studies a number of potential confounders are likely to contribute to this disparity; age, 
gender, prior changes in bodyweight as well as the timing and physiological background 
onto which experimental protocols are imposed are all likely to influence long-term 
outcomes. Here, we comprehensively assess the effects of a weight cycling paradigm in a 




All experiments were performed in compliance with Animals (Scientific Procedure) Act 1986 
under the project licence 70/6656 and 70/7502. C57BL/6 males mice (aged 8-10 weeks) 
(Harlan UK) were acclimatised for a week in ventilated cages under a 12h:12h light cycle 
(lights on at 7am) at 21-23°C with ad libitum access water. Animals were fed high fat (F) 
(60% by kcal intake; TD.06414) and control (C) diets (TD.08806, 10% by kcal intake) 
(Harlan, USA).
Weight cycling study
C57BL/6 male mice were housed in groups of 4 and fed combinations of high fat and control 
diets. The study ran for a total of 18 weeks, with animals assessed at three time points 
following dietary manipulation at 6 and 12 weeks (Supplementary Figure 1). In total 10 
dietary groups were generated; 
Time Point 1: After 6 weeks of feeding, no diet swaps; 2 groups: C, F
Male C57BL/6 mice were fed either a control diet (C) or high fat (F) diet for 6 weeks 
(n=140/group)
Time Point 2: After 12 weeks of feeding, 1 diet swap; 4 groups: CC, CF, FC, FF
After 6 weeks of feeding, C and F groups were either maintained their initial diet (CC and FF 
respectively) or switched to a high fat (CF) or control (FC) diet for the subsequent 6 weeks 
(n=35/group).
Time Point 3: After 18 weeks of feeding, 2 diet swaps; 4 groups: CCC, CFC, FCF, FFF
After 12 weeks of feeding, CC and CF groups were returned to the control diet (CCC and 
CFC groups) while FC and FF groups were placed back on a high fat diet (FCF and FFF) for 
an additional 6 weeks (n=28/group)
Body weight, food and calorie Intake
Body weight and food intake were monitored weekly. Calorie intake was measured in grams 
per cage of 4 mice (kcal) calculated from dietary composition 
Magnetic resonance Imaging
Subsets of mice from each of the 10 dietary groups underwent whole body MRI and 1H 
MRS, and localised 1H liver and muscle MRS after 4 weeks, 10 weeks and 16 weeks of their 
5assigned diet regime (n=10-12/group). Adiposity was assessed using whole body MRI and 
1H MRS, and localised 1H liver. 
Whole body MRI
After an overnight fast (16h), mice were anaesthetised with a 3% oxygen/isofluorane Body 
temperature and respiration rate were maintained during the subsequent scan. Mice were 
placed in a whole body birdcage coil and scanned in a 4.7T Unity Inova MR scanner (Varian 
Inc, USA). 50 consecutive transverse MR images of 2mm thickness covering the whole body 
were collected using a T1-weighted spin echo sequence (TR: 2.2s, TE: 20ms, FOV: 45mm x 
45mm, Matrix: 256 x 192, 2 Averages). Images were converted into a stack using ImageJ 
(Rasband) and segmentation analysis was performed using SliceOmaticTM (Tomovision®) 
to provide volumes and mass of internal and subcutaneous adipose tissue deposits. 
Analysis was performed by a trained analyst blinded to the animal treatment.
Whole Body and Localised 1H MRS
Whole body 1H MRS was performed using a single pulse sequence (SPULS) with the 
following parameters: TR 10s, pulse angle 45°, 4 averages and spectral width 20,000Hz. 
Localised 1H liver MRS was performed using a Point Resolved Spectroscopy (PRESS) 
sequence with a voxel 2x2x2mm3 placed using the images generated with whole body MRI
with the following parameters: TR 10s, TE 9ms, averages 64 and spectral width 20,000Hz.
Glucose Tolerance Test
An intraperitoneal glucose tolerance test (IPGTT) was performed on subsets of mice after 5 
weeks, 11 weeks and 17 weeks on their assigned diet regime (n=10/12 group). Mice were 
fasted overnight for 16-18 hours prior to the IPGTT. Fasting glucose was determined with a 
commercially available glucose metre before injecting a 2g/kg D-glucose bolus i.p. Blood 
glucose concentration was determined 15, 30, 60 and 120 minutes following injection. Insulin 
sensitivity was assessed from fasting concentrations of glucose and insulin using the 
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) 18.
Metabolic Hormone Assay
A MILLIPLEX MAP Mouse Metabolic Hormone Magnetic Bead Panel was used to assess 
metabolic hormone levels in the plasma (Millipore, USA). The assay was performed 
according to the manufacturer’s protocol using undiluted plasma. The plate was run on a 
MAGPIX system with xPonent software (Luminex Corp, US).
6Tissue Analysis
White adipose tissue was collected (subcutaneous, epididymal, retroperitoneal and 
mesenteric), along with brown adipose tissue, liver, pancreas, kidneys, heart and 
gastrocnemius muscle. Tissue samples were frozen on dry ice then stored at 80°C. Brains 
were sliced coronally on an ice cold brain matrix into 3 sections (forebrain, midbrain and 
hindbrain) and stored in RNAlater (Ambion) overnight at 4°C before being stored at 20° C. A 
section of the left lobe of the liver was also collected in RNAlater and stored overnight at 4°C 
before being stored at 20°C.
Gene Expression Analysis
RNA and DNA Extraction
Brain RNA was extracted using a combination of Trizol treatment and an AllPrep DNA/RNA 
micro kit (Bettscheider et al., 2011). Brains preserved in RNAlater were sectioned coronally 
at 500μm on an ice cold brain matrix using double edged razor blades. Specific regions of 
interest were dissected from 2 slices using a mouse brain atlas as a reference (Figure 
2.4.9.1.1, Franklin & Paxinos, 2007). Approximately 4μg of tissue was placed in a 2ml 
eppendorf with 350μl of RLT Buffer Plus (Qiagen, USA), 1% 2-Mercaptoethanol and 0.5% 
Reagent DX (Qiagen). The tissue was lysed and disrupted using by placing a 5mm steel 
bead (Qiagen) in the eppendorf and placing in a TissueLyser II (Qiagen) for 4 minutes at 
20Hz. The lysate was removed and added to an AllPrep DNA column and centrifuged at 
13,500rpm for 3 minutes at 4°C. The columns were then placed in new collection tubes on 
ice for DNA elution after RNA extraction was completed (as DNA is more stable than RNA). 
The flow through was added to a new 1.5ml eppendorf, along with 100μl of Trizol reagent 
(Ambion, USA) and incubated at room temperature for 5 minutes. 20μl of chloroform was 
added and the tube was vigorously shaken by hand for 15 seconds, before being left a 
further 2 minutes at room temperature. The sample was then centrifuged at 13,500rpm for 
15 minutes at 4°C, after which the aqueous phase (containing RNA) was removed and 
added to a new 1.5ml eppendorf. 70% ethanol was added to the sample to precipitate the 
RNA, then added to an RNeasy MinElute spin column (Qiagen). The columns were 
centrifuged at 13,500rpm for 3 minutes at 4°C and flow through discarded. The spin column 
membrane underwent a series of washes as described in the manufacturer’s protocol, along 
with oncolumn DNAse digestion using RNasefree DNase (Qiagen). RNA was eluted using 
12μl of THE RNA storage solution (Ambion) and stored at 80°C until further use. AllPrep 
DNA columns also underwent a series of washes as described in the manufacturer’s 
protocol and eluted twice using 30μl of EB buffer preheated to 70°C, then stored at 80°C.
7cDNA Synthesis
The amount of RNA is each sample was quantified using a NanoDrop (Thermo Scientific, 
USA). 1μg of liver RNA and 500ng of brain RNA was used to synthesise cDNA as described 
in the Thermoscript RT-PCR Systems protocol (Invitrogen, UK). RNA was added to a mix of 
oligo (dT)20 primer, 10mM deoxyribonucleotide phosphate Mix (dNTP), DEPC treated water. 
The samples were incubated at 65°C for 5 minutes and immediately placed on ice. The 
samples were then incubated with 5x cDNA synthesis buffer, 0.1M Dithriothreitol (DTT), 
DEPC treated water and Thermoscript Reverse Transcriptase. cDNA synthesis was 
completed by incubating the samples at 50°C for 60 minutes and terminating the reaction at 
85°C for 5 minutes, after which the samples were stored at 20°C until qPCR analysis. 
Quantitative RT-PCR 
A master mix of Platinum SYBR Green qPCR superMix-UDG, primer, ROX reference dye, 
DEPC treated water (Invitrogen) and cDNA template were prepared for qRT-PCR analysis. 
Each sample was added in triplicate to a MicroAmp Fast 96-well reaction plate (Applied 
Biosystems, USA), including a 1:5 serial dilution of the cDNA templates used for each 
primer. Expression of all genes undergoing investigation were normalised to a control gene 
(GAPDH) (Table 2.4.10.0.1, 2.4.10.0.2). The plate was sealed with a PCR specific seal 
(Invitrogen) then placed in a preheated (Applied Biosystems 7500 Fast RealTime PCR 
System) at a cycling program of 50°C for 2 minutes, 94°C for 2 minutes, 40 cycles of 95°C 
for 15 seconds, 65°C for 30 seconds, then a dissociation step of 95°C for 15 seconds, 60°C 
for 60 seconds and 95°C for 15 seconds. Gene expression analysis was performed using 
ΔΔCT values as described previously (Bookout & Mangelsdorf 2003, Bookout et al., 2006). 
Indirect calorimetry and acute exercise
Indirect calorimetry were carried out at 18 weeks on a separate group of mice (n=8/group). 
Ad libitum fed rats were then monitored for a baseline period of 24 hours. During CLAMS 
monitoring, metabolic parameters (VO2 and VCO2) were measured by indirect calorimetry. 
Exhaust air from each chamber was sampled at 30 minute intervals for a period of 1 minute. 
Sample air was sequentially passed through O2 and CO2 sensors (Columbus Instruments) 
for determination of O2 and CO2 content. In order to compare animals of differing sizes, the 
O2 consumption and CO2 production values were normalised with respect to body weight 
and O2 consumption was corrected to metabolic body size (W0.75) (9). RER was calculated 
by dividing VCO2 by VO2. Ambulatory activity of each individually housed animal was 
measured simultaneously using the optical beam technique (Opto M3, Columbus 
Instruments). Consecutive photo-beam breaks were scored as an ambulatory movement. 
Activity counts in x and z axes were recorded every minute for 24 hours and were used to 
8determine horizontal (XAMB) and vertical (ZTOT) movement respectively.  Food intake was 
measured every minute.
Statistics
All data is presented as mean ± standard error of mean (SEM) unless specified. The 
normality of the data was tested using a Kolmogorov-Smirnov test. Two-way ANOVA with 
Bonferroni correction was used to analyse continuous data, including body weight, food 
intake and CLAMS measurements. Oneway ANOVA with Bonferroni correction was 
performed between multiple groups (GraphPad Software, USA).
9Results
The effects of weight cycling on body weight, food intake, calorie consumption and 
feeding efficiency
C57BL/6 male mice were fed combinations of high fat and control diets for 18 weeks, with 
dietary changes at 6 and 12 weeks (Supplementary Figure 1). In total, 10 dietary groups 
were generated; for the initial 6 weeks mice were fed either a control diet (C) or high fat (F) 
diet (n=140/group). During the subsequent 6 weeks C and F groups were either maintained 
on their initial diet (CC and FF respectively), or switched to a high fat (CF) or control (FC) 
diet (n=35/group). For the final 6 weeks of the study, CC and CF groups were returned to the 
control diet (CCC and CFC groups), while FC and FF groups were placed back on a high fat 
diet (FCF and FFF) (n=28/group).
Cumulative changes in body weight between dietary groups are shown in Figure 1. 
Regardless of the specific weight cycling sequence, a group’s body weight consistently 
reflects the preceding dietary composition, with significant differences between high fat and 
control groups typically manifesting after the first week. Changes in food intake align with 
dietary switches (Supplementary Figure 2), as do differences in feeding efficiency and 
caloric intake (Supplementary Figure 3). The difference in caloric intake between high fat 
and normal chow groups reduced with each successive cycle and is also manifest following 
normalisation for body weight (Supplementary Figure 3).
The effects of weight cycling on body fat and lipid deposition as measured by MRI 
and MRS 
Whole body magnetic resonance imaging (MRI) and magnetic resonance spectroscopy 
(MRS) techniques provide an accurate means of quantifying internal fat depots strongly 
associated with metabolic derangement 19, 20. Measurements were recorded at 4, 10 and 16 
weeks of the diet swap. Differences in total, subcutaneous and internal white adipose tissue 
(WAT) before and after normalising for body weight are shown in Figure 2. At 4 weeks, 
animals on a high fat diet had significantly higher percentage of total (Figure 2A), 
subcutaneous (Figure 2C) and internal fat (Figure 2E) than controls (p<0.001). Similarly, at 
10 and 16 weeks, high fat feeding led to significantly increased total, subcutaneous and 
internal WAT in FF mice compared to CC controls (p<0.001). These changes persisted after 
normalisation of WAT to body weight (Figures 2B, 2D and 2F).
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FCF animals demonstrated a trend towards increased total (Figure 2B) and internal WAT 
(Figure 2E) compared to FFF mice which emerged as significant following normalisation to 
body weight (p<0.05). Fat depot weights measured following dissection at 6, 12 and 18 
weeks reflect comparable patterns in dietary groups to MRI data, including the increased 
internal adiposity in FCF compared to FFF animals (Supplementary Figure 4).
Dietary changes in intrahepatocellular lipid (IHCL) and intramyocellular lipid (IMCL) as 
measured by localised 1H MRS are shown in Figure 2G and Figure 2H respectively. By 10 
weeks, significant increases in IHCL emerge in the groups placed on a high fat diet 
compared to controls (10 week IHCL: CC: 18.0 ± 3.8 vs. CF: 50.1 ± 3.9; FF: 65.4 ± 6.2, 
p<0.01 for all, Figure 2G). After 16 weeks of feeding, FFF mice had a significantly higher 
IHCL content compared to CCC mice (16 week IHCL: CCC: 26.6 ± 3.3; FFF: 102.9 ± 9.1, 
p<0.001). Of the weight cycled groups, only FCF mice showed a significantly higher IHCL 
content compared to CCC animals (16 week IHCL: CFC: 50.3 ± 4.0; FCF: 60.9 ± 6.0, CCC 
vs FCF, p<0.05, Figure 2G). A trend towards increased IMCL content was observed in HF 
fed mice at 10 and 16 weeks but no significant differences were observed (Figure 2H).
The effects of weight cycling on metabolic markers
Table 1 shows the concentrations of circulating metabolic markers recorded at 6, 12 and 18 
weeks. Significantly elevated fasting levels of glucose and insulin were observed in all high 
fat dietary groups compared to controls, with the exception of CC vs. CF animals for 
glucose. The differences in fasting glucose and insulin were reflected in the composite 
HOMA-IR measure of insulin resistance (Table 1). 
No differences were observed in fed glucose levels between dietary groups at any stage of 
the study. Both insulin (fed) and c-peptide were significantly higher in all groups placed on a 
high fat diet for the 6 weeks prior to measurement. Plasma GP was increased in F vs. C and 
CC vs. CF groups. Significant differences in ghrelin manifested at 12 weeks (CC vs. FF, 
p<0.05) and became more pronounced at 18 weeks (CCC vs FFF, p<0.01; CFC vs. FFF, 
p<0.05). Increased plasma concentrations of leptin and resistin were observed in high fat 
groups compared to controls. No significant differences were found between dietary groups 
in the plasma levels of ß-ketone, IL-6, THF-α or MCP-1.
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The effects of weight cycling on indirect calorimetry as measured by CLAMS 
metabolic cages
CLAMS metabolic cage measurements recorded at 18 weeks are shown in Supplementary 
Figure 5. CCC and CFC mice demonstrated significantly greater O2 consumption, VO2 
production and RER during both light and dark phases compared to FCF and FFF mice 
(p<0.05 for all). A significant increase in heat production was observed in FFF compared to 
CCC mice in the dark phase (p<0.05). Vertical beam breaks (ZTOT) indicative of movement 
and rearing were significantly greater in CCC and CFC compared to FCF and FFF groups in 
the dark phase (p<0.001 for all).
The effects of weight cycling on neuronal mRNA expression
RT-qPCR was used to assess changes in mRNA expression in homeostatic and hedonic 
regions. Figure 3 shows the hypothalamic expression of the neuropeptides NPY (Figure 
3A), Agouti-related peptide (AGRP) (Figure 3B) and proopiomelanocortin (POMC) (Figure 
3C). After 6 weeks of HF feeding, F mice showed a significant increase in the expression of 
NPY compared to control animals, with no differences in POMC or AgRP expression. At 12 
weeks, CF demonstrated a significant decrease in NPY mRNA expression and increased 
POMC mRNA expression compared to CC and FF mice.  After 18 weeks of feeding, no 
differences in hypothalamic NPY, POMC or AgRP mRNA expression were observed 
between any dietary groups.
No significant differences between C and F groups were observed in either LepR or MC4R 
expression in the hypothalamus (Figure 4A) or ventral tegmental area (VTA) (Figure 4B). At 
12 weeks, FC mice showed a significant increase in hypothalamic LepR mRNA expression 
in compared to CC (p<0.001), CF (p<0.01) and FF (p<0.001) mice (Figure 4A). In the VTA, 
LepR expression was significantly lower in FF mice compared to all other groups (p<0.001 
for all, (Figure 4B)). No significant changes in MC4R expression in either the hypothalamus 
or VTA were observed between groups at 6 and 12 weeks. At 18 weeks, expression of 
MC4R in the VTA was reduced in CFC compared to CCC animals in the VTA (p<0.05, 
Figure 4D).
Assessment of dopaminergic gene expression in the hypothalamus, VTA, NAc and PFC are 
shown in Figure 5. TH expression in the hypothalamus was significantly increased in CF 
mice compared to CC mice (p<0.05) at 12 weeks (Figure 5B). CF mice also showed a 
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significant increase in D2R (p<0.05) and COMT (p>0.01) mRNA expression compared to FF 
animals (Figure 5B). In the VTA, mice fed on a high fat diet demonstrated a significant 
increase in D1R, D2R and DAT mRNA expression at 6 weeks (all p<0.05, Figure 5D). DAT 
mRNA expression was also significantly increased in CF mice compared to CC controls at 
12 weeks (p<0.05, Figure 5E). Both CF and FC mice showed a significant increase in VTA 
DAT mRNA expression compared to FF animals (Figure 5E). At 18 weeks, TH, D2R and 
DAT mRNA expression were all significantly higher in FFF mice compared to both CCC and 
FCF groups (p<0.05 for all, Figure 5F). FFF mice also had significantly higher DAT mRNA 
expression compared to CFC animals (Figure 5F). CFC mice showed a significant decrease 
in D1R mRNA and an increase in CORT mRNA expression compared to CCC mice (p<0.05 
for both, Figure 5F). 
At 6 weeks, a significant reduction in DAT mRNA expression was recorded in both the NAc 
(p<0.01, Figure 5G) and PFC (p<0.001, Figure 5J) of F mice compared to controls 
(p<0.01). At 12 weeks, a significant decrease in D1R mRNA expression was seen in CF and 
FC groups compared to CC and FF groups, in both the NAc (p<0.05 for all, Figure 5H) and 
PFC (p<0.05 for all, Figure 5K). DAT expression in FC mice was also significantly increased 
compared to CC mice in the NAc (p<0.01, Figure 5H) and PCF (p<0.00, Figure 5K). In the 
PFC, FC DAT mRNA expression was also significantly higher than CF and FF groups 
(p<0.001 for all, Figure 5K). In the PFC, a significant decrease in D2R mRNA expression 
was seen in CF compared to FF mice (p<0.05, Figure 5K). D2R mRNA expression was 
significantly increased in CFC (p<0.01) and FCF (p<0.05) groups compared to CCC controls 




A considerable amount of conflicting data exists regarding the long-term effects of weight-
cycling in both human and animal studies. Here, we implemented a weight cycling protocol 
in a murine model, measuring a wide array of markers associated with energy homeostasis; 
including feeding, body composition, circulating gut hormones, lipid and muscle metabolism, 
indirect calorimetry and neuronal signalling in the central nervous system (CNS). While the 
majority of outcomes aligned with changes in diet, the effects of weight cycling events on 
several key markers indicate the development of an adverse metabolic phenotype.
The 6 week cycle duration in our protocol was chosen in order to measure the metabolic 
flexibility of animals following intervals inducing rapid weight gain or loss. Previous studies 
implementing a 4 week interval reported weight cycled animals failed to reach the body 
weight observed in mice maintained on a high fat diet 21, 22. Conversely, a weight cycling 
study that employed 7 weeks cycle duration revealed extended periods of high fat feeding 
impinge on subsequent weight loss following a return to a control diet 23. We therefore chose 
a 6 week interval in order to reduce the confounding effects of differences in body weight 
between feeding groups. In addition, mice in ‘adolescence/ early adulthood” at 8-10 weeks of 
age were selected so as to reduce the influence of early life programming effects 24.
In accord with previous weight-cycling studies, we found changes in body weight, calorie 
intake and feeding efficiency aligned with dietary switches 21, 25. Furthermore, significant 
differences between high fat and control groups in these parameters were lost following any 
subsequent period in which animals were placed on the same diet. Six week dietary intervals 
therefore appear to provide sufficient time for groups to normalise body weight and feeding. 
It should be noted that cycled mice had a non-significant trend towards increased body 
weight after three weight cycles. In addition, the magnitude of difference in calorie intake and 
feeding efficiency between high fat and normal chow groups reduced with each successive 
dietary switch following normalisation for body weight. Together these data suggest that 
multiple cycling may reduce the ability to reach a control body weight, as previously 
indicated 21.
Increases in internal and ectopic fat deposition are strongly associated with dyslipidaemia, 
cardiovascular disease and type 2 diabetes 26, 27. Excessive dietary fat intake has been 
shown to overload the capacity for lipid storage in subcutaneous adipose tissue, leading to 
an initial increase in internal depots and ectopically, in organs such as the muscle and liver 
28, 29
. Individual adipose depots also respond differentially to an energy deficit, with a 
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preferential loss of fat from visceral compared to subcutaneous stores 30, 31. Together, these 
data indicate key differences in depot flexibility following fluctuations in dietary fat intake 32. 
There have been contradictory reports regarding the effects of weight-cycling on adiposity 
and body composition; with several studies indicating changes in percentage lean mass and 
an increase in visceral adiposity 8, 33-35, while others show no effects 5, 6, 36, 37.
In our model we demonstrate body fat deposition is highly responsive to changes in diet, 
with significant increases in all compartments following transfer to a high fat diet. We found 
no difference in adipose tissue between FC and CC, or CFC and CCC groups, indicating 
that 6 weeks of a control diet is sufficient to normalise these depots following a high fat diet 
cycle. However, both MRI and dissection data corroborate a significantly increased internal 
adiposity in weight cycled FCF compared to FFF animals, with no differences in 
subcutaneous stores. These results indicate that weight-cycling alters the response to a high 
fat diet, leading to preferential fat deposition in internal depots. The changes observed in 
intrahepatocellular lipid (IHCL) are not suggestive of any additionally negative effects of 
weight cycling. Rather, IHCL appears to reflect long-term dietary consequences, with 
differences between groups only manifesting later in the study, and increases directly 
proportional to the duration of time animals spend on a high fat diet. Similarly, analyses of 
metabolic markers and indirect calorimetry data indicate groups vary by diet, with no 
additional effects of weight-cycling.
It could be argued that the effects of a single high fat diet interval in the CFC group are 
reflected in non-significant trends towards increased IHCL, insulin, glucose, glucagon and 
leptin compared to CCC controls. Furthermore, weight-cycled FCF animals showed trends 
towards increased leptin, resistin, glucagon and inflammatory markers compared to FFF 
animals, in accord with their elevated levels of abdominal fat. While these trends did not 
reach statistical significance, these data serve to inform the timescale of changes in various 
markers following weight cycling events; with significant differences in adiposity manifesting 
before changes in more established clinical outcomes.
There is little consensus regarding the effects of weight cycling on hypothalamic 
neuropeptide expression, with variability in cycle length, feeding state, animal age and 
dietary constituents likely to be major contributing factors. Following the switch to a high fat 
diet, the anticipated decrease in orexigenic neuropeptides such as NPY and AgRP often 
disappear after prolonged exposure 38, 39, while other studies demonstrate a delayed 
decrease in NPY after 9 weeks of a cafeteria style HF diet 40 or no effect at all 41. Here, we 
noted an unexpected increase in hypothalamic expression of NPY in HFD compared to 
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control animals after a single cycling event. At 12 weeks the neuropeptide profile is 
somewhat clearer, with a reduction in NPY, an increase in POMC and a trend towards 
decreased AgRP in CF compared to CC animals indicating a decrease in appetite in 
response to maintained weight gain. It would be tempting to suggest that the lack of 
difference in neuropeptide profiles at 18 weeks in the consequent CCC and CFC groups is 
indicative of a reduction in sensitivity of the system, induced by weight cycling events. 
However, no differences in POMC or AGRP were noted at 6 weeks and FC and FF groups 
do not show clear patterns of expression. Future studies, which incorporate additional time 
points, fed and fasted state measurements and analyses of specific hypothalamic nuclei will 
be required to fully resolve the effects of weight cycling on feeding centres within the CNS. 
Similarly, no clear patterns of expression for MC4R, leptin receptor or dopamine mRNA were 
seen either in the hypothalamic or ventral tegmental area at any time-point. A more detailed 
analysis which differentiates between the orexigenic and orexigenic neurones that leptin and 
MC4 receptors present on both onto 42, 43 will be required. 
Previous studies which demonstrated a negative correlation between BMI and dopamine 
receptor availability in the striatum led to the “reward deficit” hypothesis, whereby a 
deficiency in dopamine signalling leads to overeating and obesity 44, 45, and is supported by 
much of the subsequent animal model data 46, 47. In contrast, the results presented here do 
not replicate these findings, with animals placed on a high fat diet for 18 weeks showing an 
increase in D2R and TH mRNA expression in the VTA, suggestive of increased dopamine 
signalling. These increases in dopamine signalling in various reward centres were not 
observed after 12 weeks of HF feeding but closely resembled those observed after 6 weeks 
of HF feeding. Together these results may suggest differences in dopaminergic gene 
expression are not the product of a gradual change in one direction, but represent differential 
expression according to the time spent feeding on a HF diet. More work will be required to 
determine if this is the result of producing a new “set point” for body weight homeostasis. 
Ultimately, the lack of a coherent narrative arising from the neuropeptide and dopamine-
related gene expression data highlight the need for a more in depth analysis of weight 
cycling on the neuronal control of energy homeostasis. Despite this uncertainty, we 
demonstrate multiple weight cycling events have an acute effect on fat composition, 
specifically increasing the amount and proportion of the metabolically adverse internal 
adipose. These data, in conjunction with our 6 week cycling model, are suggestive of an 
altered, adverse phenotype arising from rapid fluctuations in body weight.
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Figure Legends
Figure 1 Cumulative changes in body weight in weight cycled animals. Cumulative 
changes in body weight recorded in mice placed on combinations of high fat (F) or normal fat 
22
(C) diet for recorded at 6 (C, F), 12 (CC, CF, FC, FF) and 18 weeks (CCC, CFC, FCF, FFF). 
(A) CCC vs. FFF; (B) CCC vs. CFC, (C) CFC vs. FCF and (D) FCF vs. FFF. ○: CCC; ▲: 
CFC ; ▼: FCF; : FFF; dotted lines indicate at dietary switch points at 6 and 12 weeks. Data 
presented as mean ± sem; n=28/group; statistical analysis performed using Two-Way 
ANOVA with Bonferroni Correction;** = p<0.01; *** = p<0.001
Figure 2 The effects of weight cycling on body fat and lipid deposition as measured 
by MRI and MRS. Changes in white adipose tissue (WAT) measured by MRI and ectopic fat 
deposition measured by MRS, in mice placed on combinations of high fat (F) or normal fat 
(C) measured at 4 (C, F), 10 (CC, CF, FC, FF) and 16 weeks (CCC, CFC, FCF, FFF). (A) 
Total WAT; (B) Total WAT normalised to body weight; (C) Subcutaneous WAT; (D) 
Subcutaneous WAT normalised to body weight; (E) Internal WAT; (F) Internal WAT 
normalised to body weight; (G) Intrahepatocellular Lipid (IHCL); (H) Intramyocellular Lipid 
(IMCL). Data presented as mean ± sem; n=10/group; statistical analysis performed using an 
ANOVA with Bonferroni post-hoc test; * = p<0.05, ** = p<0.01; *** = p<0.001
Figure 3: The effects of weight cycling on hypothalamic neuropeptide expression. RT-
qPCR was used to assess hypothalamic neuropeptide expression in fold change (arbitrary 
units) at 6 (C, F), 12 (CC, CF, FC, FF) and 18 weeks (CCC, CFC, FCF, FFF). (A) NPY; (B) 
AgRP; (C) POMC. Data presented as mean ± sem; n=5-8/group; statistical analysis 
performed using an ANOVA with Bonferroni post-hoc test; * = p<0.05, ** = p<0.01 
Figure 4: The effects of weight cycling on receptor expression in the hypothalamus 
and ventral tegmental region (VTA). RT-qPCR was used to assess changes in leptin 
receptor (LepR) and melanocortin 4 receptor (MC4R) gene at 6 (C, F), 12 (CC, CF, FC, FF) 
and 18 weeks (CCC, CFC, FCF, FFF). (A) LepR: Hypothalamus; (B) LepR: VTA; (C) MC4R: 
Hypothalamus; (D) MC4R: VTA. Data presented as mean ± sem; n=5-8/group; statistical 
analysis performed using a One-Way ANOVA with Bonferroni correction; * = p<0.05, ** = 
p<0.01; *** = p<0.001
